Neurosense Therapeuti -CW23NRSNWPreferred / convertible
13F holders, Q1 2026 (March 31)3holders
0new positions
0sold out
$0.20avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding Neurosense Therapeuti -CW23 (NRSNW) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Empery Asset Management, LP ($20K), Clear Street Group Inc. ($13K) and UBS Group AG ($64).
- Company
- Neurosense Therapeuti -CW23
- CUSIP
- M74240116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 3 holders
| Empery Asset Management, LP | — | No change | 100,402 | $20K |
| Clear Street Group Inc. | — | No change | 63,385 | $13K |
| UBS Group AG | — | No change | 1,163 | $64 |
"% of holder's portfolio" is NRSNW's weight in each manager's 13F, not the share of Neurosense Therapeuti -CW23 the manager owns.